794 related articles for article (PubMed ID: 18945211)
1. Inhibition of energy-producing pathways of HepG2 cells by 3-bromopyruvate.
Pereira da Silva AP; El-Bacha T; Kyaw N; dos Santos RS; da-Silva WS; Almeida FC; Da Poian AT; Galina A
Biochem J; 2009 Feb; 417(3):717-26. PubMed ID: 18945211
[TBL] [Abstract][Full Text] [Related]
2. Effect of the antitumoral alkylating agent 3-bromopyruvate on mitochondrial respiration: role of mitochondrially bound hexokinase.
Rodrigues-Ferreira C; da Silva AP; Galina A
J Bioenerg Biomembr; 2012 Feb; 44(1):39-49. PubMed ID: 22322891
[TBL] [Abstract][Full Text] [Related]
3. 3-Bromopyruvic Acid Inhibits Tricarboxylic Acid Cycle and Glutaminolysis in HepG2 Cells.
Jardim-Messeder D; Moreira-Pacheco F
Anticancer Res; 2016 May; 36(5):2233-41. PubMed ID: 27127128
[TBL] [Abstract][Full Text] [Related]
4. Contributions of glycolysis and oxidative phosphorylation to adenosine 5'-triphosphate production in AS-30D hepatoma cells.
Nakashima RA; Paggi MG; Pedersen PL
Cancer Res; 1984 Dec; 44(12 Pt 1):5702-6. PubMed ID: 6498833
[TBL] [Abstract][Full Text] [Related]
5. Interaction of Na+ and K+ transport with aerobic energy metabolism in slices of Morris hepatoma 3924A.
Galeotti T; van Rossum GD; Russo MA; Palombini G
Cancer Res; 1976 Nov; 36(11 Pt 1):4175-84. PubMed ID: 184927
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial bioenergetic background confers a survival advantage to HepG2 cells in response to chemotherapy.
Loiseau D; Morvan D; Chevrollier A; Demidem A; Douay O; Reynier P; Stepien G
Mol Carcinog; 2009 Aug; 48(8):733-41. PubMed ID: 19347860
[TBL] [Abstract][Full Text] [Related]
7. Novel therapy for malignant pleural mesothelioma based on anti-energetic effect: an experimental study using 3-Bromopyruvate on nude mice.
Zhang X; Varin E; Briand M; Allouche S; Heutte N; Schwartz L; Poulain L; Icard P
Anticancer Res; 2009 Apr; 29(4):1443-8. PubMed ID: 19414400
[TBL] [Abstract][Full Text] [Related]
8. Enhanced antitumor activity of 3-bromopyruvate in combination with rapamycin in vivo and in vitro.
Zhang Q; Pan J; Lubet RA; Komas SM; Kalyanaraman B; Wang Y; You M
Cancer Prev Res (Phila); 2015 Apr; 8(4):318-26. PubMed ID: 25644152
[TBL] [Abstract][Full Text] [Related]
9. Control of cellular proliferation by modulation of oxidative phosphorylation in human and rodent fast-growing tumor cells.
Rodríguez-Enríquez S; Vital-González PA; Flores-Rodríguez FL; Marín-Hernández A; Ruiz-Azuara L; Moreno-Sánchez R
Toxicol Appl Pharmacol; 2006 Sep; 215(2):208-17. PubMed ID: 16580038
[TBL] [Abstract][Full Text] [Related]
10. Circumventing the Crabtree effect: replacing media glucose with galactose increases susceptibility of HepG2 cells to mitochondrial toxicants.
Marroquin LD; Hynes J; Dykens JA; Jamieson JD; Will Y
Toxicol Sci; 2007 Jun; 97(2):539-47. PubMed ID: 17361016
[TBL] [Abstract][Full Text] [Related]
11. c-Jun N-terminal kinase regulates mitochondrial bioenergetics by modulating pyruvate dehydrogenase activity in primary cortical neurons.
Zhou Q; Lam PY; Han D; Cadenas E
J Neurochem; 2008 Jan; 104(2):325-35. PubMed ID: 17949412
[TBL] [Abstract][Full Text] [Related]
12. Separate and concurrent use of 2-deoxy-D-glucose and 3-bromopyruvate in pancreatic cancer cells.
Xiao H; Li S; Zhang D; Liu T; Yu M; Wang F
Oncol Rep; 2013 Jan; 29(1):329-34. PubMed ID: 23076497
[TBL] [Abstract][Full Text] [Related]
13. Targets of 3-bromopyruvate, a new, energy depleting, anticancer agent.
Dell'Antone P
Med Chem; 2009 Nov; 5(6):491-6. PubMed ID: 19534685
[TBL] [Abstract][Full Text] [Related]
14. Transport of sugars and amino acids in bacteria. XV. Comparative studies on the effects of various energy poisons on the oxidative and phosphorylating activities and energy coupling reactions for the active transport systems for amino acids in E. coli.
Anraku Y; Kin E; Tanaka Y
J Biochem; 1975 Jul; 78(1):165-79. PubMed ID: 1104599
[TBL] [Abstract][Full Text] [Related]
15. 3-bromopyruvate inhibits glycolysis, depletes cellular glutathione, and compromises the viability of cultured primary rat astrocytes.
Ehrke E; Arend C; Dringen R
J Neurosci Res; 2015 Jul; 93(7):1138-46. PubMed ID: 25196479
[TBL] [Abstract][Full Text] [Related]
16. Metabolic response to MMS-mediated DNA damage in Saccharomyces cerevisiae is dependent on the glucose concentration in the medium.
Kitanovic A; Walther T; Loret MO; Holzwarth J; Kitanovic I; Bonowski F; Van Bui N; Francois JM; Wölfl S
FEMS Yeast Res; 2009 Jun; 9(4):535-51. PubMed ID: 19341380
[TBL] [Abstract][Full Text] [Related]
17. Ifosfamide metabolite chloroacetaldehyde inhibits cell proliferation and glucose metabolism without decreasing cellular ATP content in human breast cancer cells MCF-7.
Knouzy B; Dubourg L; Baverel G; Michoudet C
J Appl Toxicol; 2010 Apr; 30(3):204-11. PubMed ID: 19774546
[TBL] [Abstract][Full Text] [Related]
18. Energy-dependent volume regulation in primary cultured cerebral astrocytes.
Olson JE; Sankar R; Holtzman D; James A; Fleischhacker D
J Cell Physiol; 1986 Aug; 128(2):209-15. PubMed ID: 3015986
[TBL] [Abstract][Full Text] [Related]
19. [RNA biosynthesis in the ascitic cells of Ehrlich's carcinoma and Zajdela's hepatoma under conditions of blocked oxidative phosphorylation].
Shilov LA
Vopr Onkol; 1977; 23(9):55-9. PubMed ID: 198951
[TBL] [Abstract][Full Text] [Related]
20. 3-Bromopyruvate regulates the status of glycolysis and BCNU sensitivity in human hepatocellular carcinoma cells.
Sun X; Sun G; Huang Y; Hao Y; Tang X; Zhang N; Zhao L; Zhong R; Peng Y
Biochem Pharmacol; 2020 Jul; 177():113988. PubMed ID: 32330495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
